HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE COVER ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) Submit a letter to the editor Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Sokoloff, M. H. Articles by Belldegrun, A. Search for Related Content PubMed PubMed Citation Articles by Sokoloff, M. H. Articles by Belldegrun, A.

CA: A Cancer Journal for Clinicians, Vol 46, Issue 5 284-302, Copyright © 1996 by American Cancer Society

ARTICLES

Current management of renal cell carcinoma

M. H. Sokoloff, J. B. deKernion, R. A. Figlin and A. Belldegrun
Department of Urology, University of California, Los Angeles, School of Medicine, USA.

Renal cell carcinoma is the most common malignancy of the kidney and accounts for about three percent of all adult neoplasms. This article reviews the clinical presentation, diagnosis, staging, and treatment of this disease.

This article has been cited by other articles:

				S. G. Silverman, K. Tuncali, E. vanSonnenberg, P. R. Morrison, S. Shankar, N. Ramaiya, and J. P. Richie Renal Tumors: MR Imaging-guided Percutaneous Cryotherapy--Initial Experience in 23 Patients Radiology, August 1, 2005; 236(2): 716 - 724. [Abstract] [Full Text] [PDF]

				R. Katz-Brull, N. M. Rofsky, M. M. Morrin, I. Pedrosa, D. J. George, M. D. Michaelson, R. P. Marquis, M. Maril, C. Noguera, and R. E. Lenkinski Decreases in free cholesterol and fatty acid unsaturation in renal cell carcinoma demonstrated by breath-hold magnetic resonance spectroscopy Am J Physiol Renal Physiol, April 1, 2005; 288(4): F637 - F641. [Abstract] [Full Text] [PDF]

				M. Sumitomo, T. Asano, J. Asakuma, T. Asano, A. Horiguchi, and M. Hayakawa ZD1839 Modulates Paclitaxel Response in Renal Cancer by Blocking Paclitaxel-Induced Activation of the Epidermal Growth Factor Receptor-Extracellular Signal-Regulated Kinase Pathway Clin. Cancer Res., January 15, 2004; 10(2): 794 - 801. [Abstract] [Full Text] [PDF]